These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 27465835

  • 1. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I, Navarro S, Picci P, Llombart-Bosch A.
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [Abstract] [Full Text] [Related]

  • 2. Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma.
    Machado I, López Guerrero JA, Navarro S, Mayordomo E, Scotlandi K, Picci P, Llombart-Bosch A.
    Virchows Arch; 2013 Jun; 462(6):665-71. PubMed ID: 23681112
    [Abstract] [Full Text] [Related]

  • 3. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
    Davis JL, Horvai AE.
    Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
    [Abstract] [Full Text] [Related]

  • 4. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
    Jiang L, Liu J, Wei Q, Wang Y.
    Diagn Pathol; 2020 Nov 11; 15(1):135. PubMed ID: 33176814
    [Abstract] [Full Text] [Related]

  • 5. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
    Li M, Cai YP, Lu KY, Chen Y, Zhu X, Yin Y, Tang J.
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep 08; 45(9):631-5. PubMed ID: 27646893
    [Abstract] [Full Text] [Related]

  • 6. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
    Machado I, Navarro S, Giner F, Alberghini M, Bertoni F, Llombart-Bosch A.
    Virchows Arch; 2010 Jul 08; 457(1):87-9. PubMed ID: 20552365
    [No Abstract] [Full Text] [Related]

  • 7. SOX9 and SATB2 immunohistochemistry cannot reliably distinguish between osteosarcoma and chondrosarcoma on biopsy material.
    Sharma AE, Pytel P, Cipriani NA.
    Hum Pathol; 2022 Mar 08; 121():56-64. PubMed ID: 35016891
    [Abstract] [Full Text] [Related]

  • 8. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
    Chen CY, Zhang HZ, Jiang ZM, Zhou J, Chen J, Liu L.
    Zhonghua Bing Li Xue Za Zhi; 2016 Jun 08; 45(6):387-92. PubMed ID: 27256046
    [Abstract] [Full Text] [Related]

  • 9. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
    Devaney K, Vinh TN, Sweet DE.
    Hum Pathol; 1993 Nov 08; 24(11):1211-25. PubMed ID: 7503935
    [Abstract] [Full Text] [Related]

  • 10. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
    Gomez-Brouchet A, Mourcin F, Gourraud PA, Bouvier C, De Pinieux G, Le Guelec S, Brousset P, Delisle MB, Schiff C.
    Hum Pathol; 2010 Sep 08; 41(9):1220-30. PubMed ID: 20399482
    [Abstract] [Full Text] [Related]

  • 11. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma.
    Salas S, de Pinieux G, Gomez-Brouchet A, Larrousserie F, Leroy X, Aubert S, Decouvelaere AV, Giorgi R, Fernandez C, Bouvier C.
    Virchows Arch; 2009 Jan 08; 454(1):81-7. PubMed ID: 19050913
    [Abstract] [Full Text] [Related]

  • 12. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
    Lee AF, Hayes MM, Lebrun D, Espinosa I, Nielsen GP, Rosenberg AE, Lee CH.
    Appl Immunohistochem Mol Morphol; 2011 May 08; 19(3):233-8. PubMed ID: 21084965
    [Abstract] [Full Text] [Related]

  • 13. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
    Conner JR, Hornick JL.
    Histopathology; 2013 Jul 08; 63(1):36-49. PubMed ID: 23701429
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.
    Oda Y, Walter H, Radig K, Röse I, Neumann W, Roessner A.
    J Cancer Res Clin Oncol; 1995 Jul 08; 121(11):667-73. PubMed ID: 7593131
    [Abstract] [Full Text] [Related]

  • 15. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S, Khozaei A, Shamsdin SA, Emami MJ, Khademolhosseini F.
    Iran J Immunol; 2013 Dec 08; 10(4):229-37. PubMed ID: 24375064
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
    Machado I, Yoshida A, López-Guerrero JA, Nieto MG, Navarro S, Picci P, Llombart-Bosch A.
    Pathol Res Pract; 2017 Sep 08; 213(9):1048-1053. PubMed ID: 28864350
    [Abstract] [Full Text] [Related]

  • 17. SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Sangoi AR, Kshirsagar M, Horvai AE, Roma AA.
    Int J Gynecol Pathol; 2017 Mar 08; 36(2):140-145. PubMed ID: 27294605
    [Abstract] [Full Text] [Related]

  • 18. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS, Dittmer KE, Aberdein D, Thompson KG.
    Vet Pathol; 2016 Jul 08; 53(4):781-7. PubMed ID: 26926085
    [Abstract] [Full Text] [Related]

  • 19. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
    Park YK, Yang MH, Park HR.
    Skeletal Radiol; 1996 Jan 08; 25(1):13-7. PubMed ID: 8717113
    [Abstract] [Full Text] [Related]

  • 20. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
    Malik AT, Alexander JH, Mayerson JL, Khan SN, Scharschmidt TJ.
    Clin Orthop Relat Res; 2020 Oct 08; 478(10):2284-2295. PubMed ID: 32667758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.